November 3, 2006
Vancouver, BC – Mr. John Meekison, iCo Therapeutics CFO, will present at the Rodman & Renshaw 8th Annual Healthcare Conference. He delivers his webcast conference on November 7th at 12:05 p.m. EST from the Adams Room at the New York Palace Hotel.
“The Rodman & Renshaw conference is a great forum to introduce iCo to US institutional investors as the conference focuses on small to mid-cap life science companies”, comments Meekison.
iCo Therapeutics is one of only 18 private companies at the meeting. The remaining 242 companies are publicly traded.
Meekison’s presentation can be seen on November 7th at 12:05 EST at http://www.wsw.com/webcast/rrshq10/icothera/
Mr. John Meekison is available for comment and interview.
About iCo Therapeutics, Inc.
iCo Therapeutics Inc. is an emerging, Vancouver-based biotechnology company focused on developing pre-existing drugs for a range of new conditions affecting isolated biological environments – areas such as the eye, spinal cord, or joints – where locally-administered application of these therapies would have minimal systemic distribution and fewer safety issues.
For more information, visit the company website at: https://icotherapeutics.com.
Business Development Contact:
Dr. John Clement, CTO
Mr. John Meekison, CFO